Department of Psychology and Behavioural Sciences

Lisa Maria Wu

Cancer-related cognitive impairment in non-CNS cancer patients: Targeted review and future action plans in Europe

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperReviewResearchpeer-review

  • Charlotte Sleurs, Tilburg University, KU Leuven
  • ,
  • Ali Amidi
  • Lisa M. Wu
  • David Kiesl, Johannes Kepler University of Linz
  • ,
  • Philipp Zimmer, Dortmund University
  • ,
  • Marie Lange, Universite de Caen, Ligue Nationale Contre le Cancer, Normandie Université
  • ,
  • Anne Rogiers, Brugmann University Hospital
  • ,
  • Benedicte Giffard, Ligue Nationale Contre le Cancer, Universite de Caen
  • ,
  • Giulia Binarelli, Centre Georges-Francois Leclerc, Universite de Caen
  • ,
  • Cindy Borghgraef, Université Libre de Bruxelles
  • ,
  • Sabine Deprez, KU Leuven
  • ,
  • Mylène Duivon, Centre Georges-Francois Leclerc, Universite de Caen, Ligue Nationale Contre le Cancer
  • ,
  • Michiel De Ruiter, Netherlands Cancer Institute
  • ,
  • Sanne Schagen, Netherlands Cancer Institute, University of Amsterdam
  • ,
  • Djihane Ahmed-Lecheheb, Centre Georges-Francois Leclerc, Universite de Caen
  • ,
  • Hélène Castel, Universite de Rouen, Normandie Université
  • ,
  • Cecilie R. Buskbjerg
  • Mélanie Dos Santos, Centre Georges-Francois Leclerc, Universite de Caen
  • ,
  • Florence Joly, Centre Georges-Francois Leclerc, Universite de Caen, Ligue Nationale Contre le Cancer
  • ,
  • Joy Perrier, Universite de Caen
  • ,
  • On behalf of the European Cancer and Cognition Consortium (ECCC)

Cancer-related cognitive impairment (CRCI) has increasingly been identified over the last two decades in non-CNS system cancer patients. Across Europe, researchers have contributed to this effort by developing preclinical models, exploring underlying mechanisms and assessing cognitive and quality of life changes. The ultimate goal is to develop interventions to treat patients experiencing CRCI. To do so, new challenges need to be addressed requiring the implementation of multidisciplinary research groups. In this consensus paper, we summarize the state of the art in the field of CRCI combined with the future challenges and action plans in Europe. These challenges include data sharing/pooling, standardization of assessments as well as assessing additional biomarkers and neuroimaging investigations, notably through translational studies. We conclude this position paper with specific actions for Europe based on shared scientific expert opinion and stakeholders involved in the Innovative Partnership for Action Against Cancer, with a particular focus on cognitive intervention programs.

Original languageEnglish
Article number103859
JournalCritical Reviews in Oncology/Hematology
Number of pages10
Publication statusPublished - Dec 2022

Bibliographical note

Publisher Copyright:
© 2022 Elsevier B.V.

    Research areas

  • Biomarkers, Cancer-related cognitive impairment (CRCI), Clinical, European consortium, Neuroimaging, Preclinical, Rehabilitation, Risk factors

See relations at Aarhus University Citationformats

ID: 286306382